MINI FUTURE LONG - VIRBAC Stock

Certificat

DE000ME6C962

Real-time Bid/Ask 05:54:57 2024-07-03 EDT
6.62 EUR / 6.77 EUR +25.14% Intraday chart for MINI FUTURE LONG - VIRBAC
Current month+11.46%
1 month-29.61%
Date Price Change
24-07-02 5.35 -6.14%
24-07-01 5.7 +18.75%
24-06-28 4.8 -8.57%
24-06-27 5.25 -5.58%
24-06-26 5.56 +1.65%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 06:48 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying VIRBAC
Issuer Morgan Stanley
WKN ME6C96
ISINDE000ME6C962
Date issued 2024-01-03
Strike 280.2
Maturity Unlimited
Parity 10 : 1
Emission price 9.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.73
Lowest since issue 4.8
Spread 0.15
Spread %2.22%

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
337.5 EUR
Average target price
373.3 EUR
Spread / Average Target
+10.62%
Consensus